A1A: MULTI-USER RESEARCH CORE FACILITIES- MOLECULAR & CELLULAR BIOLOGY CORE LAB

A1A：多用户研究核心设施 - 分子

• 批准号: 8357065
• 负责人: Jacqueline Jeanette Stevens
• 金额: $ 16.37万
• 依托单位: JACKSON STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-06-01 至 2012-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8357065
• 关键词: Address; Applications Grants; Biomedical Research; Cell Culture Techniques; Core Facility; Data; Development; Engineering; Environment; Environmental Health; Equipment; Faculty; Fostering; Funding; Genetic Engineering; Grant; Individual; Institution; Laboratories; Minority; Mission; Molecular; Molecular Biology; Molecular and Cellular Biology; Peer Review; Pilot Projects; Productivity; Publications; Recombinants; Research; Research Personnel; Research Project Grants; Resources; Science; Services; Source; Students; Techniques; Technology; Technology Transfer; Training; United States National Institutes of Health; Universities; abstracting; college; cost; instrumentation; operation; programs; success

The Molecular and Cellular Biology (MCB) Core Laboratory is one of fourteen multi-user core facilities in the College of Science, Engineering and Technology (CSET) at Jackson State University (JSU). The MCB Core Laboratory has been supported by the National Institutes of Health/Research Centers for Minority Institutions NIH/RCMI since the development of the Center for Environmental Health at JSU. This facility is equipped with shared equipment to conduct research in environmental health and biomedical science using molecular biology and recombinant DMA technologies. The facility is staffed with a faculty manager and a lab technician. During the current RCMI grant cycle, the MCB Core Laboratory has contributed to 52 peer-reviewed publications and 131 abstracts and presentations. MCB Core users have also received grants totaling $11,519,460 and submitted 5 pending grant proposals. Overall, the MCB Core Laboratory has had a tremendous impact on the development of biomedical research and the success of the RCMI Program at JSU. The facility currently supports the needs of RCMI investigators and their research personnel, as well as other faculty and students who are involved in biomedical research. The MCB Core Laboratory has recently been enhanced by the purchase of new equipment (phosphoimager and DMA sequencer) with funds from other sources. However, additional support from the NIH is critical for the continued operation of this biomedical research resource. Hence, the specific aims of the MCB Core Laboratory in this new application are: 1) To continue to provide a variety of services and technical support in molecular biology and DMA technology by offering equipment access, expert advice, demonstration of techniques, operation of equipment, participation in discussion and data interpretation, and hands-on-training in molecular biology and cell culture among RCMI investigators, pilot project recipients, and other faculty; 2) To increase faculty training in recombinant DMA technology to strengthen faculty development and technology transfer; 3) To provide a research environment and instrumentation for investigators to pursue biomedical research opportunities and enhance overall research productivity; and 4) To foster collaborative research relationships among RCMI investigators and other MCB core users at JSU and other research intensive institutions.

分子和细胞生物学(MCB)核心实验室是杰克逊州立大学(JSU)科学、工程和技术学院(CSET)的14个多用户核心设施之一。自联合州立大学环境卫生中心成立以来，妇幼保健品核心实验室得到了国立卫生研究院/少数民族机构研究中心的支持。 该设施配备了共享设备，利用分子生物学和重组DMA技术进行环境健康和生物医学科学研究。该设施配备了一名教员经理和一名实验室技术人员。在本RCMI赠款周期内，妇幼保健委核心实验室为52份同行评议出版物和131份摘要和专题介绍作出了贡献。MCB核心用户还收到了总额为11,519,460美元的赠款，并提交了5份待批的赠款提案。 总体而言，MCB核心实验室对生物医学研究的发展和JSU的RCMI计划的成功产生了巨大的影响。该设施目前支持RCMI研究人员及其研究人员以及参与生物医学研究的其他教职员工和学生的需求。最近用其他来源的资金购买了新设备(磷光成像仪和DMA测序仪)，从而加强了妇幼保健局核心实验室。 然而，来自美国国立卫生研究院的额外支持对这一生物医学研究资源的继续运营至关重要。因此，MCB核心实验室在这一新应用中的具体目标是：1)继续提供分子生物学和DMA技术方面的各种服务和技术支持，提供设备访问、专家建议、技术演示、设备操作、参与讨论和数据解释以及RCMI研究人员、试点项目接受者和其他教师在分子生物学和细胞培养方面的动手培训；2)增加重组DMA技术的教师培训，以加强教师队伍的发展和 (3)为研究人员提供一个研究环境和工具，以寻求生物医学研究机会，并提高整体研究效率；及(4)促进皇家医学研究院的研究人员与联合州立大学和其他研究密集机构的其他医学会核心用户之间的合作研究关系。